Hca Healthcare Inc - HCA STOCK NEWS

Sarah Cannon Research Institute, in partnership with US Oncology Research and Ontada, is set to present over 65 abstracts at the American Society of Hematology (ASH) Annual Meeting from Dec. 10-13. This collaboration, formed in November 2022, enhances patient access to clinical trials across 250 locations in 26 states. More than 40 investigators will showcase advancements in blood cancer treatments, including innovative therapies like CAR T-Cell Therapy. Key presentations include significant studies on sickle cell disease and advanced Hodgkin lymphoma.

HCA Healthcare has launched a collaboration with Musicians On Call (MOC) to enhance patient experience through live music. This initiative includes a $1 million investment to develop MOC’s online platform, which aims to improve access to music programs in hospitals. MOC has positively impacted over 1 million people since its inception. The new platform could increase MOC's reach to up to ten times more hospitals. The partnership kicked off with a performance by Charles Esten at TriStar Centennial Medical Center, marking MOC’s first in-person event since the pandemic.

HCA Healthcare announced that 81% of its hospitals earned an “A” or “B” in the fall 2022 Leapfrog Hospital Safety Grade, significantly surpassing the national average of 57%. Notably, 82 hospitals received an “A,” with Rose Medical Center and St. David’s Medical Center achieving a “Straight A” designation since 2012. The Leapfrog Group evaluates hospitals based on patient safety measures. HCA emphasizes a culture of safety, aided by initiatives like the REDUCE MRSA study showing a 44% reduction in bloodstream infections.

HCA Healthcare announced the successful collection of 19,423 pounds of unused or expired medications during its fourth annual 'Crush the Crisis' opioid take back day on October 29, 2022. This marks a record for the event, surpassing last year's 15,566 pounds. Since its inception in 2017, approximately 54,644 pounds of medication have been collected. The initiative involved all 15 U.S. divisions and over 100 collection sites across 17 states, raising awareness about the dangers of opioid misuse.

HCA Healthcare (NYSE: HCA) will present at three healthcare conferences in November 2022. The first is on November 8 at 9:50 am PST during the Credit Suisse 31st Annual Healthcare Conference in Rancho Palos Verdes, CA. The second presentation is on November 16 at 8:40 am EST at the 4th Annual Wolfe Research Healthcare Conference in New York, NY. Lastly, on November 17 at 2:00 pm CST, they will participate in the Stephens Annual Investment Conference in Nashville, TN. Live audio webcasts and materials will be available on their website.

HCA Healthcare (NYSE:HCA) announced its fourth annual 'Crush the Crisis' opioid take back day on October 29, 2022, to combat opioid misuse. Over 100 facilities will partner with local law enforcement to collect unused medications. In 2021, over 107,000 drug overdose deaths occurred in the U.S., marking a 15% increase from 2020. Last year's event collected 15,566 pounds of medication. HCA Healthcare has donated $750,000 to develop safer pain management protocols and utilizes big data from 35 million patient encounters to enhance care.

HCA Healthcare, one of the leading healthcare providers in the U.S., announced a significant organizational change effective January 1, 2023. This involves creating a third operating group to enhance alignment with the company’s strategy and improve long-term performance. Jon Foster has been promoted to Executive Vice President & Chief Operating Officer, overseeing key operational areas. Additionally, several leadership promotions were announced across various divisions. This restructuring aims to streamline decision-making and provide focused support for the company’s networks.

HCA Healthcare reported third-quarter 2022 results, revealing revenues of $14.971 billion, a decrease from $15.276 billion in Q3 2021. Net income fell to $1.134 billion, or $3.91 per diluted share, compared to $2.269 billion, or $7.00 per diluted share, last year. Adjusted EBITDA was $2.902 billion, down from $3.224 billion. Same facility admissions declined by 1.5%, while equivalent admissions increased 2.3%. Hurricane Ian impacted operations with estimated costs of $35 million. The company also declared a quarterly dividend of $0.56 per share, payable on December 28, 2022.